U.K. cost watchdogs turn away rare disease med Crysvita
admin 15th June 2018 Uncategorised 0Patients in the U.K. won’t have access to X-linked hypophosphatemia med Crysvita under a ruling by NICE.
More: U.K. cost watchdogs turn away rare disease med Crysvita
Source: fierce